Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

PPBT

PPBT News

Newswire

07:51

Purple Biotech shares surge 21.09% premarket after positive CAPTN-3 preclinical data shows anti-tumor activity in PD-1 resistant models and platform versatility.

07:16

Purple Biotech shares surge 12.74% premarket on positive preclinical data from CAPTN-3 platform showing tumor regression.

08:08

Purple Biotech Achieves Manufacturing Milestone, Anticipates Cash Runway into 2027.

16:24

Healthcare Stocks Rise and Fall in After-Market Session: Meihua Intl Medical Techs and Purple Biotech Lead the Way

07:41

Purple Biotech Achieves Commercially Viable Yield for IM1240 Tri-Specific Antibody.

View More

About PPBT

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More